We will provide updates every evening of the 2011 San Antonio Breast Cancer Symposium.
2011 SAN ANTONIO BREAST CANCER SYMPOSIUM NEWS ROUNDUP
December 7, 2011
abstracts reaffirm the benefits of using Zometa with endocrine therapy
to prevent recurrence. There is now a test for recurrence risk in DCIS
patients. The poor prognosis of overweight women is further studied.
And, directly in line with our Before Forty Initiative, Hispanic women
are diagnosed younger than non-hispanics and are more likely to develop a
very aggressive, non-responsive form of Triple Negative Breast Cancer.
They have a high mortality rate. Imagine if our Before Forty Initiative
was able to help these women? We are working hard to do just that.
Abstracts below. More to follow tomorrow.
Please go HERE for full report